Chagas cardiomyopathy: an update of current clinical knowledge and management: a scientific statement from the American Heart Association

MCP Nunes, A Beaton, H Acquatella, C Bern… - Circulation, 2018 - Am Heart Assoc
Background: Chagas disease, resulting from the protozoan Trypanosoma cruzi, is an
important cause of heart failure, stroke, arrhythmia, and sudden death. Traditionally …

[HTML][HTML] 3rd Guideline for Perioperative Cardiovascular Evaluation of the Brazilian Society of Cardiology

DM Gualandro, PC Yu, B Caramelli… - Arquivos Brasileiros …, 2017 - SciELO Brasil
The main aim of the guidelines is to update the concepts promulgated by its two
predecessors, namely, the I and II Guidelines for Perioperative Evaluation of the Brazilian …

[HTML][HTML] 3ª Diretriz de avaliação cardiovascular perioperatória da Sociedade Brasileira de Cardiologia

DM Gualandro, PC Yu, B Caramelli… - Arquivos Brasileiros …, 2017 - SciELO Brasil
Material de distribuição exclusiva à classe médica. Os Arquivos Brasileiros de Cardiologia
não se responsabilizam pelo acesso indevido a seu conteúdo e que contrarie a …

Use of guidelines for reducing stroke risk in patients with nonvalvular atrial fibrillation: a review from a Latin American perspective

C Cantu-Brito, GS Silva… - Clinical and Applied …, 2018 - journals.sagepub.com
Atrial fibrillation (AF) is a prominent risk factor for stroke and a leading cause of death and
disability throughout Latin America. Contemporary evidence-based guidelines for the …

Rationale and design of the First Brazilian Cardiovascular Registry of Atrial Fibrillation: the RECALL study

RD Lopes, AAV de Paola, AM Lorga Filho… - American heart …, 2016 - Elsevier
Background Atrial fibrillation (AF) is an important and growing public health problem
worldwide, but data about its actual prevalence, therapeutic management, and clinical …

Antiplatelet agents in perioperative noncardiac surgeries: to maintain or to suspend?

JMDM Borges, FO de Carvalho, IA Gomes… - … and Clinical Risk …, 2018 - Taylor & Francis
Background When prescribing antiplatelet agents, physicians face the challenge of
protecting patients from thromboembolic events without inducing bleeding damage …

[HTML][HTML] Use of a mobile application for the control of anticoagulation with warfarin: a cluster randomized controlled clinical trial-Ijui/RS/Brazil

RM Moraes, ER Winkelmann, CF Colet - Brazilian Journal of …, 2022 - SciELO Brasil
To evaluate the effectiveness of an anticoagulation protocol adapted in a mobile application
(appG) for patients using warfarin. This was a cluster randomized controlled clinical trial …

[HTML][HTML] Anticoagulants and antiplatelet drugs during cataract surgery

N Kara-Junior, CR Koch, MR Santhiago… - Arquivos brasileiros de …, 2018 - SciELO Brasil
Patients undergoing cataract surgery are generally elderly, and many take drugs with
systemic effects. The surgeon must be aware of the risks of continuing or discontinuing such …

[HTML][HTML] Factors in deciding between novel and traditional oral anticoagulants to prevent embolism in atrial fibrillation patients

M Scanavacca, F Darrieux - Arquivos Brasileiros de Cardiologia, 2016 - SciELO Brasil
Atrial fibrillation (AF) is the sustained arrhythmia most frequently found in clinical practice. Its
prevalence is expected to increase in the coming decades. Its occurrence implies a …

[HTML][HTML] Examining therapeutic equivalence between branded and generic warfarin in Brazil: The WARFA crossover randomized controlled trial

C Gomes Freitas, M Walsh, EL Coutinho… - Plos one, 2021 - journals.plos.org
Objectives To determine whether the generic and branded warfarins used as anticoagulants
in Brazil are therapeutic equivalents based on their international normalized ratio (INR) …